How Alto Neuroscience, Inc. stacks up

ANRO · against 588 other Healthcare companies listed in US-listed

Valuation

8/ 100

Near the bottom of its peers.

Ranked #313 of 589 · scores higher than 3% of peers

Bars: peers in each 10-point band of the valuation score

277 peers with a valuation score of 0–9, including ANRO · Click a bar to see the companies

Why valuation scores 8?

Weighted metrics compared with all Healthcare companies.

Mainly because of its EBITDA yield, earnings yield and free cash flow yield, which are weaker than most Healthcare peers.

Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -13.1% vs peer median 4.0%
Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -9.5% vs peer median 1.5%
Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -7.7% vs peer median 0.0%

Metric by metric

Position: dot = ANRO, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	ANRO	Peer median	Better than	Weight
Earnings yieldHigher is better · 577 reported	-9.8%	-4.3%	36%	30%
EBITDA yieldHigher is better · 578 reported	-13.1%	-0.8%	27%	50%
Free cash flow yieldHigher is better · 553 reported	-7.7%	-2.3%	33%	20%
Book yieldHigher is better · 587 reported	27.5%	25.9%	53%	Context only

Ranking by valuation score

Top 5 and the companies ranked around ANRO

Rank	Company	Market cap	Valuation	Overall
1	Clinuvel Pharmaceuticals LimitedCUVL · US-listed	256M USD	98	80
2	Arbutus Biopharma CorporationABUS · US-listed	595M USD	96	97
2	CorMedix Inc.CRMD · US-listed	433M USD	96	81
2	Community Health Systems, Inc.CYH · US-listed	289M USD	96	57
2	InMode Ltd.INMD · US-listed	810M USD	96	69
⋯
313	Alumis Inc.ALMS · US-listed	841M USD	8	33
313	Altimmune, Inc.ALT · US-listed	397M USD	8	37
313	Amylyx Pharmaceuticals, Inc.AMLX · US-listed	3.7B USD	8	31
313	Annexon, Inc.ANNX · US-listed	794M USD	8
313	Alto Neuroscience, Inc.ANRO · US-listed	891M USD	8
313	Apogee Therapeutics IncAPGE · US-listed	10.2B USD	8
313	Aquestive Therapeutics, Inc.AQST · US-listed	487M USD	8	24
313	Accuray IncorporatedARAY · US-listed	17M USD	8	16
313	Arcturus Therapeutics Holdings Inc.ARCT · US-listed	271M USD	8	14

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…